athenahealth, Inc. Reports First Quarter Fiscal Year 2012 Results

  • 38% Revenue Growth Over First Quarter of 2011
  • GAAP Net Income of $2.4 Million, or $0.07 Per Diluted Share
  • Non-GAAP Adjusted Net Income of $6.3 Million, or $0.17 Per Diluted Share

WATERTOWN, Mass.--(BUSINESS WIRE)-- athenahealth, Inc. (NASDAQ: ATHN) (the “Company”), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups, today announced financial and operational results for the first quarter of fiscal year 2012. The Company will conduct a conference call tomorrow, Friday, April 27, 2012, at 8:00 a.m. Eastern Time to discuss these results and management’s outlook for future financial and operational performance.

Total revenue for the three months ended March 31, 2012, was $96.6 million, compared to $69.9 million in the same period last year, an increase of 38%.

“I am very pleased with our execution during Q1. While the U.S. health care market becomes more complex, our clients are thriving as our services allow them to profit by doing the right thing,” said Jonathan Bush, the Company’s Chairman, President, and Chief Executive Officer. “During the past quarter, we streamlined the packaging of our services with athenaOne, transitioned to an order-based athenaClinicals pricing model, and extended our athenaCoordinator service to include physician receivers. We believe that these strategies have the potential to drive broader changes in the way medical care givers coordinate health care in the U.S. and that they will bring many new senders and receivers of health information onto our cloud-based network.”

For the three months ended March 31, 2012, Non-GAAP Adjusted Gross Margin was 61.5%, down from 62.5% in the same period last year as the Company continues to invest in its newest service offering, athenaCoordinatorSM. Non-GAAP Adjusted EBITDA increased 27% to $17.1 million, or 17.7% of total revenue, from Non-GAAP Adjusted EBITDA of $13.4 million, or 19.1% of total revenue, in the same period last year. For the three months ended March 31, 2012, GAAP net income was $2.4 million, or $0.07 per diluted share, compared to $3.3 million, or $0.09 per diluted share, in the same period last year. Non-GAAP Adjusted Net Income was $6.3 million, or $0.17 per diluted share, up slightly from $5.9 million, or $0.17 per diluted share, in the same period last year. See “Use of Non-GAAP Financial Measures” below.

“I am thrilled with our performance in Q1 2012, our 49th quarter of consecutive revenue growth. Demand for our cloud-based services has increased even more with the launch of our care coordination services,” said Tim Adams, the Company’s Chief Financial Officer. “Despite our success to date, we are still early in our quest to become a health information backbone and will continue our investments in growth and innovation to achieve this goal.”

Key metrics and milestones in the first quarter of fiscal year 2012 included the following:

  • $2.1 billion in collections posted to client accounts in the first quarter of 2012, compared to $1.6 billion in the same quarter of 2011
  • 40.0 average client Days in Accounts Receivable (DAR) in the first quarter of 2012, compared to 41.0 average client DAR in the same quarter of 2011
  • 33,923 active medical providers using athenaCollector® at March 31, 2012, 24,101 of whom were physicians, compared to 27,944 providers and 19,778 physicians at March 31, 2011
  • 7,402 active medical providers using athenaClinicals® at March 31, 2012, 5,331 of whom were physicians, compared to 4,161 providers and 2,910 physicians at March 31, 2011
  • 6,800 active medical providers using athenaCommunicator® at March 31, 2012, 4,820 of whom were physicians, compared to 1,564 providers and 934 physicians at March 31, 2011

As of March 31, 2012, the Company had cash, cash equivalents, and available-for-sale investments of $133.6 million. The Company does not have any outstanding debt obligations.

Use of Non-GAAP Financial Measures

In the Company’s earnings releases, conference calls, slide presentations, and webcasts, the Company may use or discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. The Company’s earnings press releases containing such non-GAAP reconciliations can be found on the Investors section of the Company’s web site at http://www.athenahealth.com.

Conference Call Information

To participate in the Company’s live conference call and webcast, please dial 800-447-0521 (or 847-413-3238 for international calls) using conference code No. 32023096, or visit the Investors section of the Company’s web site at www.athenahealth.com. A replay will be available for one week following the conference call at 888-843-7419 (and 630-652-3042 for international calls) using conference code No. 32023096. A webcast replay will also be archived on the Company’s website.

About athenahealth

athenahealth, Inc. is a leading provider of cloud-based business services for physician practices. athenahealth’s service offerings are based on proprietary web-native practice management and electronic health record (EHR) software, a continuously updated payer knowledge-base, integrated back-office service operations, and care coordination services. For more information, please visit http://www.athenahealth.com/ or call (888) 652-8200.

Forward-Looking Statements

This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements reflecting management’s expectations for future financial and operational performance and operating expenditures, expected growth, and business outlook; statements regarding the benefits of the Company’s service offerings, the creation of a sustainable market for health information exchange, a social network for health care, and a national health IT network, statements regarding the expansion of the types of tasks the Company performs for its clients and the Company’s continued investment in growth and development; and statements found under the Company’s “Reconciliation of Non-GAAP Financial Measures to Comparable GAAP Measures” section of this release. The forward-looking statements in this release do not constitute guarantees of future performance. These statements are neither promises nor guarantees, and are subject to a variety of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: the Company’s fluctuating operating results; the Company’s variable sales and implementation cycles, which may result in fluctuations in its quarterly results; risks associated with the acquisition and integration of companies and new technologies, including those related to the Company’s ability to successfully integrate the athenaCoordinator service and successfully scale the Proxsys services and technologies to achieve expected synergies; risks associated with its expectations regarding its ability to maintain profitability; the impact of increased sales and marketing expenditures, including whether increased expansion in revenues is attained and whether impact on margins and profitability is longer term than expected; changes in tax rates or exposure to additional tax liabilities; the highly competitive industry in which the Company operates and the relative immaturity of the market for its service offerings; and the evolving and complex governmental and regulatory compliance environment in which the Company and its clients operate. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances, or otherwise. For additional disclosure regarding these and other risks faced by the Company, please see the disclosures contained in its public filings with the Securities and Exchange Commission, available on the Investors section of the Company’s website at http://www.athenahealth.com and on the SEC’s website at http://www.sec.gov.

athenahealth, Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited, in thousands, except per share amounts)

 
March December

31, 2012

31, 2011
 
Assets
Current assets:
Cash and cash equivalents $ 52,491 $ 57,781
Short-term investments 63,550 62,084
Current portion of restricted cash 4,047 -
Accounts receivable - net 53,058 49,038
Deferred tax assets 5,527 5,245
Prepaid expenses and other current assets   12,549     8,988  
Total current assets 191,222 183,136
 
Property and equipment - net 51,482 52,275
Restricted cash, net of current portion 856 5,007
Software development costs - net 8,187 6,974
Purchased intangibles - net 19,299 20,052
Goodwill 47,307 47,307
Deferred tax assets 12,191 12,532
Investments and other assets   20,360       21,503  
Total assets $ 350,904  

 

$ 348,786  
 
Liabilities & Stockholders' Equity
Current liabilities:
Accounts payable $ 4,556 $ 6,318
Accrued compensation 16,829 28,176
Accrued expenses 17,753 17,774
Current portion of deferred revenue 6,311 6,345
Current portion of deferred rent   987  

 

  960  
Total current liabilities 46,436 59,573
Deferred rent, net of current portion 2,684 2,932
Deferred revenue, net of current portion 45,173 44,281
Other long-term liabilities   3,109       5,529  
Total liabilities 97,402 112,315
 
Stockholders' equity:

Preferred stock, $0.01 par value: 5,000 shares authorized; no shares issued
and outstanding at March 31, 2012, and December 31, 2011, respectively

- -

Common stock, $0.01 par value: 125,000 shares authorized; 37,024 shares
issued, and 35,746 shares outstanding at March 31, 2012; 36,678 shares
issued and 35,400 shares outstanding at December 31, 2011.

370 367
Additional paid-in capital 261,668 247,131
Treasury stock, at cost, 1,278 shares (1,200 ) (1,200 )
Accumulated other comprehensive loss (38 ) (101 )
Accumulated deficit   (7,298 )

 

  (9,726 )
Total stockholders' equity   253,502       236,471  
Total liabilities and stockholders' equity $ 350,904     $ 348,786  

athenahealth, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited, in thousands, except per share amounts)

 
Three Months Ended
March 31,
2012   2011
 
Revenue:
Business services $ 93,549 $ 67,486
Implementation and other   3,017     2,444  
Total revenue   96,566     69,930  
 
Expense:
Direct operating 38,798 27,270
Selling and marketing 23,728 16,941
Research and development 7,168 5,079
General and administrative 16,199 11,719
Depreciation and amortization   5,486     3,398  
Total expense   91,379     64,407  
 
Operating income 5,187 5,523
Other income (expense)   134     33  
 
Income before income taxes 5,321 5,556
Income tax provision   (2,893 )   (2,305 )
 
Net income $ 2,428   $ 3,251  
 
Net income per share - Basic $ 0.07 $ 0.09
 
Net income per share - Diluted $ 0.07 $ 0.09
 
Weighted average shares used in computing net income per share:
Basic 35,535 34,678
Diluted 36,996 35,657

athenahealth, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited, in thousands)

 
Three Months Ended
March 31,
2012   2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income $ 2,428 $ 3,251
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 6,276 3,858
Amortization of premium on investments 354 381
Provision for uncollectible accounts 287 259
Excess tax benefit from stock-based awards (2,829 ) (2,175 )
Deferred income tax 40 136
Increase in fair value of contingent consideration 71 114
Stock-based compensation expense 5,633 4,005
Loss on interest rate derivative contract - (65 )
Changes in operating assets and liabilities:
Accounts receivable (4,307 ) (6,103 )
Prepaid expenses and other current assets (847 ) 542
Other long-term assets 94 79
Accounts payable 3,054 2,124
Accrued expenses 77 1,791
Accrued compensation (11,347 ) (6,593 )
Deferred revenue 858 2,731
Deferred rent   (221 )   (352 )
Net cash (used in) provided by operating activities   (379 )   3,983  
 
CASH FLOWS FROM INVESTING ACTIVITIES:
Capitalized software development costs (2,839 ) (1,469 )
Purchases of property and equipment (10,383 ) (2,067 )
Proceeds from sales and maturities of investments 25,224 54,054
Purchases of short-term and long-term investments (25,904 ) (48,766 )
Decrease in restricted cash   104     2,887  
Net cash (used in) provided by investing activities   (13,798 )   4,639  
 
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock under stock plans 7,958 2,125
Taxes paid related to net share settlement of restricted stock awards (1,825 ) -
Excess tax benefit from stock-based awards 2,829 2,175
Payment of contingent consideration accrued at acquisition date (104 ) (2,558 )
Payments on long-term debt and capital lease obligations   -     (793 )
Net cash provided by financing activities   8,858     949  
Effects of exchange rate changes on cash and cash equivalents   29     67  
Net decrease in cash and cash equivalents (5,290 ) 9,638
Cash and cash equivalents at beginning of period   57,781     35,944  
Cash and cash equivalents at end of period $ 52,491   $ 45,582  
 
Non-cash transactions
Property and equipment recorded in accounts payable and accrued expenses $ 784   $ 179  
 
Tax benefit recorded in prepaid expenses and other current assets $ 2,774   $ 2,120  
$ 177
Additional disclosures
 
Cash paid for interest $ -   $ 177  
 
Cash paid for taxes $ 733   $ 241  

athenahealth, Inc.

STOCK-BASED COMPENSATION EXPENSE

(Unaudited, in thousands)

 

Set forth below is a breakout of stock-based compensation expense for the three
months ended March 31, 2012 and 2011:

 
Three months ended March 31,
2012   2011
Stock-based compensation expense charged to:
Direct operating $ 908 $ 605
Selling and marketing 1,672 923
Research and development 765 530
General and administrative   2,288   1,947
Total $ 5,633 $ 4,005
athenahealth, Inc.
CASH, CASH EQUIVALENTS, AND AVAILABLE-FOR-SALE INVESTMENTS
(Unaudited, in thousands)
 

Set forth below is a breakout of total cash, cash equivalents, and available-for-sale
investments as of March 31, 2012, and December 31, 2011:

   
March 31, December 31
2012 2011
 
Cash, cash equivalents $ 52,491 $ 57,781
Short-term investments 63,550 62,084
Long-term investments* 17,570 18,619
   
Total $ 133,611 $ 138,484
*The Company has purchased certain available-for-sale investments that had a maturity date longer than one-year, which it classifies in investments and other assets on the condensed consolidated balance sheet.

athenahealth, Inc.

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES

TO COMPARABLE GAAP MEASURES

(Unaudited, in thousands, except per share amounts)

 
The following is a reconciliation of the non-GAAP financial measures used by the Company to describe the Company’s financial results determined in accordance with accounting principles generally accepted in the United States of America (GAAP). An explanation of these measures is also included below under the heading “Explanation of Non-GAAP Financial Measures.”
 
While management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying performance of the Company’s business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with the Company’s results of operations as determined in accordance with GAAP.
 
Please note that these figures may not sum exactly due to rounding.
 

Non-GAAP Adjusted Gross Margin

Set forth below is a presentation of the Company’s “Non-GAAP Adjusted Gross Profit” and “Non-GAAP Adjusted Gross Margin,” which represents Non-GAAP Adjusted Gross Profit as a percentage of total revenue.
(unaudited, in thousands)   Three Months Ended
March 31,
2012   2011
 
Total revenue $ 96,566 $ 69,930
Direct operating expense   38,798   27,270
Total revenue less direct
operating expense 57,768 42,660
Add: Stock-based compensation expense
allocated to direct operating expense 908 605
Add: Amortization of purchased intangibles 753 460
   
Non-GAAP Adjusted Gross Profit $ 59,429 $ 43,725
 
Non-GAAP Adjusted Gross Margin 61.5% 62.5%

Non-GAAP Adjusted EBITDA

Set forth below is a reconciliation of the Company’s “Non-GAAP Adjusted EBITDA” and “Non-GAAP Adjusted EBITDA Margin,” which represents Non-GAAP Adjusted EBITDA as a percentage of total revenue.
(unaudited, in thousands)   Three Months Ended
March 31,
2012   2011
 
Total revenue $ 96,566 $ 69,930
 
GAAP net income 2,428 3,251
Add: Provision for income taxes 2,893 2,305
Add: Total other (income) expense (134 ) (33 )
Add: Stock-based compensation expense 5,633 4,005
Add: Depreciation and amortization 5,486 3,398
Add: Amortization of purchased intangibles 753 460
   
Non-GAAP Adjusted EBITDA $ 17,059   $ 13,386  
 
Non-GAAP Adjusted EBITDA Margin 17.7 % 19.1 %

Non-GAAP Adjusted Operating Income

Set forth below is a reconciliation of the Company’s “Non-GAAP Adjusted Operating Income” and “Non-GAAP Adjusted Operating Income Margin,” which represents Non-GAAP Adjusted Operating Income as a percentage of total revenue.
(unaudited, in thousands)   Three Months Ended
March 31,
2012   2011
 
Total revenue $ 96,566 $ 69,930
 
GAAP net income 2,428 3,251
Add: Provision for income taxes 2,893 2,305
Add: Total other (income) expense (134 ) (33 )
Add: Stock-based compensation expense 5,633 4,005
Add: Amortization of purchased intangibles 753 460
   
Non-GAAP Adjusted Operating Income $ 11,573   $ 9,988  
 
Non-GAAP Adjusted Operating Income Margin 12.0 % 14.3 %

Non-GAAP Adjusted Net Income

Set forth below is a reconciliation of the Company’s “Non-GAAP Adjusted Net Income” and “Non-GAAP Adjusted Net Income per Diluted Share.”
(unaudited, in thousands except per share amounts)   Three Months Ended
March 31,
2012   2011
 
GAAP net income $ 2,428 $ 3,251

Add: (Gain) loss on interest rate derivative contract

- (65 )
Add: Stock-based compensation expense 5,633 4,005
Add: Amortization of purchased intangibles   753     460  
Sub-total of tax deductible items 6,386 4,400
(Less): Tax impact of tax deductible items (1) (2,554 ) (1,760 )
   
Non-GAAP Adjusted Net Income $ 6,260   $ 5,891  
 
Weighted average shares - diluted 36,996 35,657
 
Non-GAAP Adjusted Net Income per Diluted Share $ 0.17 $ 0.17
 
(1) - Tax impact calculated using a statutory tax rate of 40%

 

(unaudited, in thousands except per share amounts)

Three Months Ended

March 31,

2012

2011

 

GAAP net income per share - diluted

$

0.07

$

0.09

Add: (Gain) loss on interest rate derivative contract

-

-

Add: Stock-based compensation expense

0.15

0.12

Add: Amortization of purchased intangibles

0.02

0.01

 

   

Sub-total of tax deductible items

0.17

0.13

(Less): Tax impact of tax deductible items (1)

(0.07

)

(0.05

)

           

Non-GAAP Adjusted Net Income per Diluted Share

$

0.17

 

$

0.17

 
 

Weighted average shares - diluted

36,996

35,657

 

(1) - Tax impact calculated using a statutory tax rate of 40%

Explanation of Non-GAAP Financial Measures

The Company reports its financial results in accordance with accounting principles generally accepted in the United States of America, or GAAP. However, management believes that, in order to properly understand the Company's short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management also uses results of operations before such items to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in the Company’s ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of the Company’s ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing the Company’s financial and operational performance and comparing this performance to its peers and competitors.

Management defines “Non-GAAP Adjusted Gross Profit” as total revenue, less direct operating expense, plus (1) stock-based compensation expense allocated to direct operating expense and (2) amortization of purchased intangibles, and “Non-GAAP Adjusted Gross Margin” as Non-GAAP Adjusted Gross Profit as a percentage of total revenue. Management considers these non-GAAP financial measures to be important indicators of the Company’s operational strength and performance of its business and a good measure of its historical operating trends. Moreover, management believes that these measures enable investors and financial analysts to closely monitor and understand changes in the Company’s ability to generate income from ongoing business operations.

Management defines “Non-GAAP Adjusted EBITDA” as the sum of GAAP net income before provision for income taxes, total other (income) expense, stock-based compensation expense, depreciation and amortization, and amortization of purchased intangibles and “Non-GAAP Adjusted EBITDA Margin” as Non-GAAP Adjusted EBITDA as a percentage of total revenue. Management defines “Non-GAAP Adjusted Operating Income” as the sum of GAAP net income before provision for income taxes, total other (income) expense, stock-based compensation expense, and amortization of purchased intangibles, and “Non-GAAP Adjusted Operating Income Margin” as Non-GAAP Adjusted Operating Income as a percentage of total revenue. Management defines “Non-GAAP Adjusted Net Income” as the sum of GAAP net income before (gain) loss on interest rate derivative contract, stock-based compensation expense, amortization of purchased intangibles, and any tax impact related to these items, and “Non-GAAP Adjusted Net Income per Diluted Share” as Non-GAAP Adjusted Net Income divided by weighted average diluted shares outstanding. Management considers all of these non-GAAP financial measures to be important indicators of the Company’s operational strength and performance of its business and a good measure of its historical operating trends, in particular the extent to which ongoing operations impact the Company’s overall financial performance.

Management excludes each of the items identified below from the applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item:

  • Stock-based compensation expense — excluded because these are non-cash expenses that management does not consider part of ongoing operating results when assessing the performance of the Company’s business, and also because the total amount of expense is partially outside of the Company’s control because it is based on factors such as stock price, volatility, and interest rates, which may be unrelated to the Company’s performance during the period in which the expense is incurred.
  • Amortization of purchased intangibles — purchased intangibles are amortized over their estimated useful life and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Thus, including such charge does not accurately reflect the performance of the Company’s ongoing operations for the period in which such charge is incurred.
  • Gains and losses on interest rate derivative contract — excluded because, until they are realized, to the extent these gains or losses impact a period presented, management does not believe that they reflect the underlying performance of ongoing business operations for such period.



CONTACT:

athenahealth, Inc.
Dana Quattrochi (Investors)
Director, Investor Relations
617-402-1329
[email protected]
or
athenahealth, Inc.
Amanda Cheslock (Media)
212-446-1884
[email protected]

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Technology  Data Management  Internet  Software  Telecommunications  Practice Management  Health  Hospitals  Mobile/Wireless  Other Health

MEDIA:

Suggested Articles

Nearly 10,000 patients involved in research studies were impacted by a third-party privacy breach that may have exposed their medical diagnoses.

Veterans Health Administration medical facilities currently have a paper medical record backlog that if stacked up would be 5.15 miles high, according to the…

The Department of Health and Human Services announced proposed changes to privacy restrictions on patients' substance use treatment records.